findmyKOL

Diane Thiboutot, MD

Enriched profile

Professor and Vice Chair for Research, Department of Dermatology · Penn State College of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Hershey, PA · Northeast · United StatesSpecialtyDermatologyFocusAcne / Hidradenitis
Last active 2024findmyKOL type: EliteLatest publication2024Online presenceverified 2026Payments2021–2023NIH funding1997–2018

Diane Thiboutot is Professor and Vice Chair for Research, Department of Dermatology at Penn State College of Medicine. OpenAlex indexes 261 publications with 16,088 citations (h-index 65); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Dermatology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Diane Thiboutot, MD, is Professor and Vice Chair for Research, Department of Dermatology at Penn State College of Medicine / Penn State Health Milton S. Hershey Medical Center. The public record shows 261 publications with 16,088 citations (h-index 65), centered on Acne / Hidradenitis. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 4 companies, 5 NIH-funded awards (1997–2018).

  • Most recent indexed publication: 2024 · Experimental dermatology
  • Top research focus: Acne / Hidradenitis
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 4 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Acne / Hidradenitis1 trialAcne Vulgaris1 trial

Research focus

OpenAlex concept fingerprint
Acne / Hidradenitis

Drugs & molecules

across trials, industry payments and publications
Akliefgeneric · TrifaroteneClinical trials—Industry payments2Publications—Cosentyxgeneric · SecukinumabClinical trials—Industry payments2Publications—Libtayogeneric · CemiplimabClinical trials—Industry payments2Publications—Cibinqogeneric · AbrocitinibClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Galderma Laboratories, L.P.Clinical trials—Industry payments2Novartis Pharmaceuticals CorporationClinical trials—Industry payments2Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments2Galderma R&DClinical trials1Industry payments—Pfizer Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
261publications

Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.

16,088citations

Total citations across indexed works.

65h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
4companies · 2021–2023

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
5NIH grants · 1997–2018

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

4 companies reported payments to CMS in program years 2021–2023. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    45.3%
    Azole Antifungal15.4%
    Ketoconazole100%
    Part D≥12 patients
    Tetracycline-class Drug14%
    Doxycycline Hyclate100%
    Part D≥11 patients

    + 2 more classes in this area

  • Sensory organs

    22.9%
    Corticosteroid22.9%
    Clobetasol Propionate45%Betamethasone Diprop Augmented29%Betamethasone Dipropionate27%
    Part D<11 patients
  • Dermatology

    16.4%
    Corticosteroid16.4%
    Triamcinolone Acetonide100%
    Part D≥24 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

5 NIH research awards on record, funded 1997–2018 per NIH RePORTER. The latest:

All 27 award records: search, sort and filter.Explore →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/diane-thiboutot-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Dermatology residency

    Penn State Milton S. Hershey Medical Center (1989-1992); internal medicine internship

    1989
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctor.webmd.com ↗
  • MD

    Pennsylvania State University College of Medicine

    1988
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctor.webmd.com ↗
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.